and a specificity of 91% for identifying patients with active EoE [73]. Further studies are needed to determine whether measurement of mucosal impedance in patients with EoE could obviate the need for biopsy to assess disease activity.
In summary, using baseline and direct mucosal impedance to assess diseases that alter mucosal permeability is promising, but further studies are needed before widespread clinical application can be recommended.
References
1 1 Silny J. Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. J Gastrointest Motil 1991; 3:151–162.
2 2 Imam H, Shay S, Ali A, Baker M. Bolus transit patterns in healthy subjects: a study using simultaneous impedance monitoring, videoesophagram, and esophageal manometry. Am J Physiol Gastrointest Liver Physiol 2005; 288:G1000–1006.
3 3 Srinivasan R, Vela MF, Katz PO, et al. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol 2001; 280:G457–462.
4 4 Tutuian R, Vela MF, Shay SS, Castell DO. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol 2003; 37:206–215.
5 5 Tutuian R, Vela MF, Balaji N, et al. Esophageal function testing using combined multichannel intraluminal impedance and manometry. Multicenter study in healthy volunteers. Clin Gastroenterol Hepatol 2003; 1:174–182.
6 6 Tutuian R, Castell DO. Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol 2004; 99:1011–1019.
7 7 Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995; 108:1897–1907.
8 8 Hirano I, Richter JE. American College of Gastroenterology guidelines: esophageal reflux testing. Am J Gastroenterol 2007; 102:668–685.
9 9 Vela M. Nonacid reflux: detection by multichannel intraluminal impedance and pH. Clinical significance and management. Am J Gastroenterol 2009; 104:277–280.
10 10 Vela MF, Camacho‐Lobato L, Srinivasan R, et al. Intraesophageal impedance and pH measurement of acid and nonacid reflux: effect of omeprazole. Gastroenterology 2001; 120:1599–1606.
11 11 Sifrim D, Holloway RH, Silny J, et al. Composition of the post‐prandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96:647–655.
12 12 Mainie I, Tutuian R, Shay S, et al. Acid and nonacid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicenter study using combined ambulatory impedance‐pH monitoring. Gut 2006; 55:1398–1402.
13 13 Hila A, Agrawal A, Castell DO. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol 2007; 5:172–177.
14 14 Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in Symptomatic patients on PPI therapy. Am J Gastroenterol 2005; 100:283–289.
15 15 Stein HJ, Feussner H, Kauer W, et al. Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg 1994; 167:163–168.
16 16 Velasco N, Pope CE, Gannan RM, et al. Measurement of esophageal reflux by scintigraphy. Dig Dis Sci 1984, 29:977–982.
17 17 Iftikhar SY, Ledingham S, Evans DF, et al. Alkaline gastrooesophageal reflux: dual probe pH monitoring. Gut 1995; 37:465–470.
18 18 Vaezi MF, Richter JE. Importance of duodeno‐gastro‐esophageal reflux in the medical outpatient practice. Hepatogastroenterology 1999; 46:40–47.
19 19 Stein HJ, Kauer WKH, Feussner H, et al. Bile acids as components of the duodenogastric refluxate: detection, relationship to bilirubin, mechanism of injury, and clinical relevance. Hepatogastroenterology 1999; 46:66–73.
20 20 Girelli CM, Cuvello P, Limido E, et al. Duodenogastric reflux: an update. Am J Gastroenterol 1996; 91:648–653.
21 21 DeVault KR, Georgeson S, Castell DO. Salivary stimulation mimics esophageal exposure to refluxed duodenal contents. Am J Gastroenterol 1993; 88:1040–1043.
22 22 Smout AJPM. Ambulatory monitoring of esophageal pH and pressure. In: Castell DO, Richter JE, eds. The Esophagus, 3rd edn. Philadelphia: Lippincott Williams & Wilkins; 1999, pp. 119–133.
23 23 Agrawal A, Tutian R, Hila A, et al. Ingestion of acidic foods mimics gastroesophageal reflux during pH monitoring. Dig Dis Sci 2005; 50:1916–1920.
24 24 Silny J, Knigge KP, Fass J, et al. Verification of the intraluminal multiple electrical impedance measurement for the recording of gastrointestinal motility. J Gastrointest Motil 1993; 5:107–122.
25 25 Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro‐oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, nonacid, and gas reflux. Gut 2004; 53:1024–1031.
26 26 Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux. Am J Gastroenterol 2005; 100:265–269.
27 27 Shay S, Tutuian R, Sifrim D, et al. Twenty‐four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004; 99:1037–1043.
28 28 Zerbib F, des Varannes SB, Roman S, et al. Normal values and day‐to‐day variability of 24‐h ambulatory oesophageal impedance‐pH monitoring in a Belgian‐French cohort of healthy subjects. Aliment Pharmacol Ther 2005; 22:1011–1021.
29 29 Pandolfino JE, Vela MF. Esophageal reflux monitoring. Gastrointest Endosc 2009; 69:917–930.
30 30 Roman S, Bruley des Varannes S, et al. Ambulatory 24‐h oesophageal impedance‐pH recordings: reliability of automatic analysis for gastro‐oesophageal reflux assessment. Neurogastroenterol Motil 2006; 18:978–986.
31 32 Jung KW, Jung HY, Romero Y, Katzka D, Murray JA. Impact of display alternatives in the determination of bolus handling: a study using high‐resolution manometry with impedance. Am J Gastroenterol. 2011; 106(10):1854–1857. doi:10.1038/ajg.2011.233.
32 33 Lin Z, Nicodème F, Lin CYY et al. Parameters for quantifying bolus retention with high‐resolution impedance manometry. Neurogastroenterol Motil 2014; 26:929–36.
33 34 Chen CL, Yi CH. Clinical correlates of dysphagia to oesophageal dysmotility: studies using combined manometry and impedance. Neurogastroenterol Motil 2008; 20:611–7.
34 35 Clayton SB, Rife C, Kalbfleisch JH et al. Viscous impedance is an important indicator of abnormal esophageal motility. Neurogastroenterol Motil 2013; 25:563.
35 36 Tutuian R, Castell DO. Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: Studies using combined impedancemanometry. Clin Gastroenterol Hepatol 2004; 2:230–6.
36 37 Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 2015; 27(2):160–174. doi:10.1111/nmo.12477.
37 38 Tutuian R, Mainie I, Agrawal A, Gideon RM, Katz PO, Castell DO. Symptom and function heterogenicity among patients with distal esophageal spasm: studies using combined impedance‐manometry. Am J Gastroenterol. 2006; 101(3):464–469. doi:10.1111/j.1572‐0241.2006.00408.x.
38 39 Bredenoord AJ, Weusten BL, Sifrim D, et al. Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut 2004; 53:1561–5.
39 40 Karamanolis G, Triantafyllou K, Tsiamoulos Z et al. Effect of sleep on excessive belching: a 24‐hour impedance‐pH study. J Clin Gastroenterol 2010; 44:332–4.
40 41 Hemmink GJM, Cate TL, Bredenoord AJ et al. Speech therapy in patients with excessive supragastric belching–a pilot study. Neurogastroenterol Motil